Ensuring cancer patients can conceive without delaying chemotherapy
The "Sehha" Group, part of "BureHealth," successfully completed a fertility preservation program at the Corniche Fertility Center for a 30-year-old patient diagnosed with recurrent ovarian cancer. This treatment preserved her future fertility options without delaying urgent chemotherapy initiation. Following the diagnosis, the patient was urgently referred for fertility preservation options prior to treatment. An consultation was scheduled within a week, and freezing procedures commenced the next day, with embryo freezing chosen as the preferred option. This step reflects the center's commitment to integrating oncology and reproductive medicine services, ensuring fertility preservation options are provided alongside treatment without delay, thereby maintaining the patient's future chances of conception.
Notice: This Is an AI-Generated Summary
Comments (0)